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Available online 28 January 2017Objective: To describe the clinical phenotype of 7 families with Autosomal Dominant Lateral Temporal Lobe
Epilepsy (ADLTE) related to Reelin (RELN) mutations comparing the data with those observed in 12 LGI1-mutated
pedigrees belonging to our series.
Methods: Out of 40 Italian families with ADLTE, collected by epileptologists participating in a collaborative study of
the Commission for Genetics of the Italian League against Epilepsy encompassing a 14-year period (2000–2014),
7 (17.5%)were found toharbor heterozygousRELNmutations. Thewhole series also included12 (30%) LGI1mutated
families and 21 (52.5%) non-mutated pedigrees. The clinical, neurophysiological, and neuroradiological findings of
RELN and LGI1mutated families were analyzed.
Results: Out of 28 affected individuals belonging to 7 RELNmutated families, 24 had sufficient clinical data available
for the study. In these patients, the epilepsy onset occurred at a mean age of 20 years, with focal seizures character-
ized by auditory auras in about 71% of the cases, associated in one-third of patientswith aphasia, visual disturbances
or other less common symptoms (vertigo or déjà-vu). Tonic–clonic seizures were reported by almost all patients
(88%), preceded by typical aura in 67% of cases. Seizureswere precipitated by environmental noises in 8% of patients
andwere completely or almost completely controlled by antiepileptic treatment in the vastmajority of cases (96%).
The interictal EEG recordings showed epileptiform abnormalities or focal slow waves in 80% of patients, localized
over the temporal regions, withmarked left predominance and conventional 1,5TMRI scans were not contributory.
By comparing these findings with those observed in families with LGI1mutations, we did not observe significant
differences except for a higher rate of left-sided EEG abnormalities in the RELN group.
Significance:Heterozygous RELNmutations cause a typical ADLTE syndrome, indistinguishable from that associated
with LGI1mutations.
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Autosomal dominant lateral temporal epilepsy (ADLTE) otherwise
known as autosomal dominant partial epilepsy with auditory features
(ADPEAF) is a genetic focal epileptic syndrome characterized by the
onset at any age, but with preponderance in young adults, of focal
seizures, either with or without impairment of consciousness or evolving
to tonic–clonic seizures, with prominent auditory features or othernder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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affected patients show normal neurological and cognitive status, normal
conventional MRI, and belong to families where one or more members
show a similar phenotype with evidence of autosomal dominant trans-
mission. This condition has been associated with leucine-rich glioma
inactivated 1 (LGI1) gene mutations [3,4]. Since then, however, it has be-
come clear that a considerable proportion of families, more than 50%,
does not carry any LGI1 abnormality and remains genetically unsolved.
Following a collaborative study promoted by the Genetic Commission
of the Italian League against Epilepsy, a large number of ADLTE families
have been collected over the time and only one-third of them have
been associated with LGI1mutations [5].
Recently, heterozygous mutations of a second gene, reelin (RELN),
have been detected in 7 previously unsolved (non-LGI1-mutated)
Italian ADLTE families through single nucleotide polymorphism-array
linkage analysis and whole exome sequencing [6]. Interestingly, these
ADLTE-related mutations significantly decreased serum levels of the
secreted protein (reelin), suggesting an inhibitory effect of mutations
on protein secretion.
To evaluate whether this new genetic basis (i.e. RELN heterozygous
mutations) is associated with distinct clinical findings, we describe
herein the clinical phenotype of such families comparing the data with
those observed in 12 LGI1-mutated pedigrees belonging to our series.
2. Material and methods
Seven RELN mutated families were discovered out of a series of 40
Italian families with ADLTE collected by epileptologists participating in
a collaborative study of the Commission for Genetics of the Italian
League against Epilepsy encompassing a 14-year period (2000–2014).
The whole series also included 12 (30%) LGI1mutated families and 21
(52.5%) non-mutated pedigrees.
The RELNmutated families were selected on the basis of the following
criteria: presence of at least two family members concordant for unpro-
voked focal seizures with auditory auras or aphasic symptoms as first
symptom, the absence of any known brain pathology, and normal
neurological examination.
Each proband and affected individual were interviewed directly and
examined by the referring clinician, either at the hospital or during a
visit to the patient's home. The clinical interview included personal
and family history, as well as details concerning the following features:
age at onset of seizures, description of ictal semiology (obtained from
the patient and an external observer), original patient's description of
auras, types of stimuli if any triggering seizures, seizure occurrence in
relation to the sleep–wake cycle, seizure frequency and response to
treatment, and past and present therapy. Each affected individual also
had a physical and neurologic examination. Medical records describing
results of neurophysiologic, neuroimaging, and history data were
collected whenever possible to supplement the clinical visits.
Routine and sleep (after afternoon nap) EEG studies as well as MRI
scans were available in all the probands and the majority of affected
individuals.
A genealogic tree was built for each pedigree, and overall data were
reviewed by two epileptologists (RM, PS), who asked for additional in-
formation if needed, and who also analyzed original EEG and/or MRI
findings if available.
After informed consent was obtained, blood samples were drawn
from each proband and DNA was extracted using standard methods.
Themethods used to test LGI1 and RELNmutations have been described
in detail elsewhere [5,6]. In brief, probands' DNA samples were tested
for LGI1mutations by direct sequencing and LGI1-negative ADLTE fam-
ilies underwent either whole exome sequencing or targeted massive
parallel sequencing to detect RELNmutations.
Because our study included publishedmutated families, we used the
information from published pedigree figures. The 12 LGI1 mutated
families have been described in detail elsewhere [2,5,7–13] whereasthe 7 pedigrees with RELN mutations have been reported limited only
to the genetic findings [6].
Differences between the two sub-groups of families (harboringRELN
and LGI1mutations, respectively) in terms of clinical, neurophysiological
and neuroradiological features were evaluated using the Fisher's exact
test. Since this study included only retrospective/published clinical infor-
mation, it did not require formal IRB approval.
3. Results
3.1. Clinical findings
We analyzed the clinical features of 7 RELNmutated families [6] and
compared the results with those observed in 12 LGI1mutated pedigrees
[5,13]. The clinical, EEG, and neuroimaging findings of each family are
reported in detail in Tables 1–2.
3.1.1. RELN mutated families
The 7 pedigrees included a total of 28 individuals (5 deceased) with
seizures and/or epilepsy. Of these cases, one suffered from one single
unprovoked seizure (of tonic–clonic type) and 3, belonging to two
families, were quoted to have “epilepsy” but no additional clinical infor-
mation was available. These patients were therefore not included in the
overall clinical description, which was limited to 24 affected individuals
(4 deceased).
The age of seizure onset ranged between 10 and 40 years, with a
mean of 20.1 years.
Patients were classified as having genetic focal epilepsy (n = 19,
79%) or epilepsy with recurrent tonic–clonic seizures, undetermined
whether focal or generalized, as the only seizure type (n = 5, 21%). All
these 5 patients, however, were deceased and detailed information
on clinical semiology, aside from a history of recurrent tonic–clonic
seizures, was lacking.
Among the 19 patients with genetic focal epilepsy, 1 (5%) had only
focal seizures evolving to tonic–clonic seizures, 3 (16%) had only focal
seizures without impairment of consciousness, and 15 (79%) had both
focal seizures evolving to tonic–clonic seizures and focal seizures with
or without impairment of consciousness. Overall, focal seizures without
impairment of consciousness were reported by 10 patients (41%), focal
seizures with impairment of consciousness by 6 patients (25%) and focal
seizures evolving to tonic–clonic seizures by 16 patients (67%). By adding
those patients with tonic–clonic seizures undetermined whether focal or
generalized, a total of 21 patients (88%) suffered fromconvulsive seizures.
Auras were reported by all the 19 patients with genetic focal epilepsy
and allowed classifying seizures as focal.
Auditory auras were the most common type, being observed in 17
cases (71%) and occurring in isolation (n = 11, 46%) or preceding some
kind of receptive aphasia (n = 3, 12%) and visual hallucinations (n = 3,
12%). Other symptoms following the auditory phenomena included
vertigo, paroxysmal headache, déjà-vu, and epigastric discomfort.
Ictal aphasia without auditory symptoms occurred in the remaining
2 cases (8%).
Sudden noises and noisy environments could precipitate the
seizures in 2 cases (8%) belonging to 2 families.
Seizures usually occurred at a low frequency, with tonic–clonic
seizures being sporadic (1 to 3 times per year, either duringwakefulness
or sleep) and focal seizures with or without impairment of conscious-
ness occurring at a variable frequency (ranging from aweekly to annual
basis). Seizure outcome was available for 16 patients. Ten individuals
(63%) were seizure-free for many years. Five patients (31%) continued
to suffer from rare auditory auras and 1 patient (6%) still had many
seizures per month. Interestingly, tonic-conic seizures were completely
controlled in all patients.
Routine and/or sleep deprivation EEGswere available in 15 out of 20
living subjects. The interictal recordings showed epileptiform abnormal-
ities (usually spikes or sharp waves) or focal slow waves in 12 patients
Table 1
Clinical and genetic details of LGI1 mutated families.
Clinical findings F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12
N° patients (a/d) 3/0 4/0 4/0 3/1 6/1 2/2 5/2 3/2 4/1 6/2 2/0 3/1
Male/female 3/0 3/1 3/1 1/3 3/4 2/2 5/2 1/4 3/2 6/2 2/0 4/0
Age (years) at onset
(range)
12 19 18–50 10 13 33–37 14–30 19–19 9 22 9 15 17–43 12 34 9–15 10–20
Seizure types
- FS or SIC (n°) 3 3 2 2 5 1 5 3 3 6 1 4
- FSETCS (n°) 3 3 2 1 3 1 5 2 3 6 2 3
- TCSUO (n°) 0 1 2 2 2 3 2 2 2 2 0 0
- UEH (n°)
Ictal symptoms
- Auditory (n°) – 3 2 1 5 1 4 3 3 5 1 1
- Aphasia (n°) 2 1 – 1 – – 3 2 – – – 0
- Visual (n°) – – – – – – 1 – – – 2 3
- Other (n°) 1 1 – 1 2 1 4 3 1 1 – –
Reflex seizures (n°) – 3 – – 1 – 2 – 1 – – –
Seizure free (n°/affected) 3/3 4/4 2/2 1/3 2/3 1/2 2/4 uk 2/4 0/5 2/2 2 3
EEG (n°) 3 3 2 1 4 2 5 4 2 3 2 3
- Ictal (findings n°) – – – lt se 1 – – – – – – – –
- Interictal (findings n°) bt sa 3 bt sa 3 n 2 lt ea 1 n 3, lt ea 1 n 2 n 3, bt ea 2 n 1,bt sa 1, lt ea 2 lt ea 2 bt sa 1, lbt ea 2 n 2 n 1,rt ea 1, lt ea 1
MRI (n°) 3 3 2 2 3 2 2 uk 2 2 2 2
- Normal (n°) 3 3 2 2 3 2 2 2 2 2 2
- Abnormal (findings n°) – – – – – – – – – – –
LGI1 1295 TNA 598 TNC 406 CNT 367 GNA 365 TNA 365 TNC 461 TNC 136 TNC 1138TNC Deletion 1118TNC 856TNC
a/d = alive/deceased; FS = focal seizures; SIC = seizure with impaired consciousness; FSETCS = focal seizures evolving to tonic–clonic seizures; TCSUO = tonic–clonic seizures of
unknown onset; UEH = unknown epilepsy history; lt = left; rt = right; bt = bilateral; n = normal; ea = epileptic activity; sa = slow activity.
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right side in 3 (20%), and both sides in 1 (7%). In 3 patients (20%), EEGs
were normal or showed aspecific abnormalities.
A conventional MRI scan was available in 12 patients. The
exams were all normal in all patients and disclosed only minor ab-
normalities in 1 case (25%), consisting of mild temporal atrophy
(n = 1).
3.1.2. LGI1 mutated families
The clinical findings of these 12 families have been reported in detail
in previous papers [5,13] and are summarized in Tables 1–2. In brief,
there were 57 patients (12 deceased) belonging to 12 families. Of these
cases, however, 6 patients were quoted to have “epilepsy” but noTable 2
Clinical and genetic details of RELN mutated families.
Clinical findings F31 F33 F14
N° patients (a/d) 5/0 5/1 4/3
Male/female 3/2 3/3 2/5
Age (years) at onset (range) 10–25 8–30 18–40
Seizure types
- FS or SIC (n°) 4 3 3
- FSETCS (n°) 4 3 2
- TCSUO (n°) 0 1 4
- UEH (n°) 1 2 0
Ictal symptoms
- Auditory (n°) 3 3 3
- Aphasia (n°) 1 – –
- Visual (n°) 1 – –
- Other (n°) 3 – 1
Reflex seizures (n°) – 0.1 –
Seizure-free (n°/affected) 2/3 0/2 4/3
EEG (n°) 4 3 4
- Ictal (findings n°) – – –
- Interictal (findings n°) lt ea 3, lt sa 1 n 1, lt sa 2 n 4
MRI (n°) 3 2 3
- Normal (n°) 3 2 3
- Abnormal (findings n°) – – 1
REELIN 2392 CNA 2531 CNT 8347 GN
a/d = alive/deceased; FS = focal seizures; SIC = seizure with impaired consciousness; FSETC
known onset; UEH = unknown epilepsy history; lt = left; rt = right; bt = bilateral; n = normadditional clinical information was available and were therefore not
included in the overall clinical description, which was limited to 51
affected individuals (10 deceased).
Age at onset ranged between 9 and 50 years (mean 17.7). Patients
were classified as having genetic focal epilepsy (n= 39, 76%) or epilepsy
with recurrent tonic–clonic seizures, undetermined whether focal or
generalized, as the only seizure type (n = 13, 24%).
Among the 39 patients with idiopathic focal epilepsy, 1 (3%) had
only focal seizures evolving to tonic–clonic seizures, 5 (12%) had only
focal seizures with or without impairment of consciousness, and
33 (85%) had both focal seizures evolving to tonic–clonic seizures and
focal seizures with or without impairment of consciousness. By adding
those patients with tonic–clonic seizures undetermined whether focalFIA F15 PAC CRR
3/1 2/0 2/0 2/0
3/1 1/1 0/2 0/2
19–24 20–24 17–17 8–12
3 2 2 2
2 2 2 1
0 0 0 0
1 0 0 0
3 2 1 2
2 – 2 –
1 1 – –
2 1 – –
– 1 – –
UK 1/1 1/1 1/1
UK 2 2 UK
– –
rt ea 2 bt sa 1, rt ea 1
UK 2 2 UK
2 2
– –
T 2288 ANG 2168ANG 9526GNA 2015 CNT
S = focal seizures evolving to tonic–clonic seizure; TCSUO = tonic–clonic seizures of un-
al; ea = epileptic activity; sa = slow activity.
Table 4
Comparison of auditory auras in both groups.




Nonspecific sounds/rumors 5 2
Plugged ears 1 1
Increased/reduced sounds 1 1
Lateralized auras 4 0
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seizures.
Auditory auraswere observed in 29 cases (57%), occurring in isolation
(n= 14, 27%) or preceding some kind of receptive aphasia (n= 7, 13%),
vertigo (n= 5, 10%), visual hallucinations (n= 2, 4%), and déjà-vu (n=
2, 4%). In 2 patients the auditory symptoms followed a visual aura.
Other ictal symptoms not associatedwith auditory auras occurred in
10 patients (20%) and included visual symptoms (n = 4, 8%), aphasia
(n = 2, 4%), déjà-vu (n = 3, 6%), and vertigo (n = 1, 2%).
Sudden noises and noisy environments could precipitate the seizures
in 7 cases (13%) belonging to 4 families.
Seizure outcome was available for 33 patients, 21 of them (64%)
being seizure-free since the first treatment and the remaining cases
continuing to suffer from focal seizures, usually at a low frequency.
Routine and/or sleep deprivation EEGs were available in 31 out of
the 45 living subjects and showed normal findings in 13 cases (42%)
or interictal focal epileptiform/slow abnormalities (usually spikes or
sharp waves) in 18 patients (58%) over the temporal regions, involving
the left side in 7 patients (22%), the right side in 1 (3%), and both sides
in 10 (32%). A conventional MRI scan was available in 25 patients and
were normal in all cases.
3.1.3. Clinical comparison between RELN and LGI1 mutated families.
The clinical features of the patients belonging to the RELN and LGI1
mutated groups did not differ significantly as to age at onset (20.1 vs
17.7 years), frequency of auditory auras (71% vs 57%), ictal aphasic
symptoms (21% vs 17%), occurrence of tonic–clonic seizures (88% vs
92%), and response to therapy (63% vs 64% of seizure freedom). Neuro-
radiological findings were substantially normal in both groups whereas
EEGs showed a lower rate of normal recordings and higher rate of left
temporal abnormalities in RELN group compared to the LGI1 group
(20 vs 42% and 53 vs 22%, respectively), the latter difference being
only mildly statistically significant (Table 3). The patients’ descriptions
of auditory auras in both groups is provided in Table 4.
3.2. Genetic findings
The genetic mutations segregating in these families have been
reported elsewhere [5,6,13] and are given in Tables 1–2.
4. Discussion
In this paperwe have described the clinical, EEG, andMRIfindings of
7 ADLTE pedigrees associated with heterozygous RELN mutations,
which had been reported in detail elsewhere by our group [5,6,13].Table 3
Clinical comparison between RELN and LGI1 mutated families.
Features LGI1 families (12) RELN fam (7) Fisher's exact test
N° pts (a/d) 51 (41/10) 24 (20/4)
Age at onset (mean/range) 17,7 (9–50) 20.1 (8–40)
Focal seizures, n°(%) 39 (76) 19 (79) 1
- Auditory 29 (57) 17 (71) 0.30
- Aphasic 9 (17) 5 (20) 1
- Visual 6 (12) 3 (12) 1
- Other 15 (29) 7 (29) 1
Tonic–clonic seizures n°(%) 47 (92) 21 (88) 0.6734
Reflex seizures n°(%) 7 (13) 2 (8%) 0.71
Seizure-free (%) 64 63 1
EEG, n° 31 15
- Normal, n°(%) 13 (42) 3 (20) 0.19
- lt epil abn, n°(%) 7 (22) 8 (53) 0.05
- rt epil abn, n°(%) 1 (3) 3 (20) 0.09
- bt epil abn, n°(%) 10 (32) 1 (7) 0.07
MRI, n° 25 12
- Abnormal, n° 0 1 0.32
a/d = alive/deceased; lt epil abn = left epileptiform abnormalities; rt epil abn = right
epileptiform abnormalities; bt epil abn = bilateral epileptiform abnormalities.By comparing these findings with those observed in families with
LGI1 mutations, we did not observe any significant difference except
for a left-sided preponderance of EEG abnormalities (53 vs 22%) in the
RELN group. This difference, however, could relate to the low number
of patients included and needs confirmation in larger series. Admittedly
the lack of significant differences between the two groups may depend
on the adoption of common and strict clinical criteria to select ADLTE
families. Therefore, our findings do not exclude that LGI1 or RELNmuta-
tionsmay be found in families not exactly fitting these inclusion criteria.
However, LGI1 mutations were not found in a vast cohort of families
with familial mesial temporal lobe epilepsy [14] and RELN mutations
have not been discovered so far in other familial focal epilepsies [6].
The clinical similarity between LGI1 and RELN mutated families
suggests that mutations of both genes should be searched for when
facing with a family showing an ADLTE phenotype, due to the lack of
any clinical clue suggesting either RELN or LGI1mutations. However, the
use of multiple gene panels should help to solve the genetic diagnosis.
In addition, the clinical similarity between LGI1 and RELN pedigrees
suggests that both genes may share similar mechanisms of action.
Reelin regulates the correct formation of laminated structures
during embryonic development and modulates dendritic growth and
synaptic plasticity at postnatal and adult stages [15]. LGI1, like Reelin,
could serve different functions during brain development and adult-
hood [16]. Reelin and LGI1 have been shown to co-localize to distinct
neurons in rat brain [6], suggesting that theremay be a functional inter-
play between the two proteins in embryonic and postnatal life, which
may be perturbed by mutations in either gene.
Homozygous RELN mutations have been reported to cause
lissencephaly and cerebellar hypoplasia, a serious neuronal-migration
recessive disorder presentingwith epilepsy and severe cognitive defect,
in three small consanguineous families [17,18]. The heterozygote indi-
viduals of these families, despite showing reduced reelin serum levels,
had normal phenotypes, likely explained by a low penetrance of RELN
mutations (estimated to be around 60%) [6] as well as by a mild clinical
expression of these mutations, since auditory symptoms may remain
unrecognized and undiagnosed for many years in some individuals.
Alternatively, it could be hypothesized that additional genetic factors
are needed to express the clinical phenotype.
Based on the neuroradiological findings of lissencephaly and
cerebellar hypoplasia caused by homozygous RELN mutations, MRI of
patients carrying heterozygous mutations could be expected to show
even minor changes compatible with neuronal migration disorder.
These signs have not been observed in our series but this may depend
on a relatively low resolution power of the available MRI scans, which
were not capable of detectingminor corticalmalformations. It is therefore
necessary to perform a study with a 3T MRI machine using advanced
neuroimaging methods (volumetry, tensor diffusion imaging, etc), to
exclude any sign of neuronal migration disorder.
Lastly in our series of 40 families with ADLTE, RELN heterozygous
mutations and LGI1 mutations accounted for 17.5% and 30% of all
pedigrees, respectively. Therefore, almost half of the families remains
unsolved; moreover, the type of functional interaction between LGI1
and RELN are still largely unknown. Additional studies are required in
the future to discover new ADLTE-associated genes and elucidate how
their mutations lead to ADLTE.
107R. Michelucci et al. / Epilepsy & Behavior 68 (2017) 103–1075. Conclusions
ADLTE associated with RELNmutations shows a typical and homoge-
neous clinical picture, identical to that observed in LGI1mutated families.
RELN mutations account for about one-fifth of ADLTE pedigrees in
Italy. Therefore the search for RELNmutations should become a routine
procedure using multiple gene panels.
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